|
Index of reports
> Cases with Fatigue (68)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sandostatin (Octreotide) where reactions include fatigue. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 68 Next >>
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Pneumonia, Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Tremor, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Feeling Jittery, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-27
Patient: female
Reactions: Abdominal Pain, Fatigue, Diarrhoea, Arthralgia, Pain in Extremity, Insomnia
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, bid
Indication: Acromegaly
Start date: 2009-07-07
Sandostatin LAR
Dosage: 20 mg, monthly
Indication: Acromegaly
Start date: 2009-07-24
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, monthly
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: male
Reactions: Abdominal Pain, Productive Cough, Pruritus, Nasopharyngitis, Metastases To Liver, Pyrexia, Faecal Volume Increased, Hot Flush, Fatigue, Cough, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Gastrointestinal Neoplasm, Diarrhoea, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Antibiotics; Morphine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Flushing, Fatigue, Diarrhoea, Pain in Extremity, Pain, Dizziness, Muscle Spasms
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Sandostatin
Dosage: every 12 hrs
Start date: 2012-08-14
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2012-07-04
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2012-07-04
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-16
Patient: male
Reactions: Jaundice, Abdominal Pain, Blood Bilirubin Increased, Confusional State, Agitation, Weight Decreased, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Malaise, Fatigue, Pleural Effusion, Cardiac Failure Congestive, Cough, Decreased Appetite, Lethargy, Blood Pressure Increased, Dyspnoea, Restlessness, Pain in Extremity, Ascites, Discomfort, Heart Rate Decreased, Abdominal Mass, Syncope, Micturition Disorder, Joint Swelling, Urine Colour Abnormal, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 20 mg, once in a month
Indication: Neuroendocrine Tumour
Start date: 2011-02-28
Other drugs received by patient: Sutent
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-13
Patient: female
Reactions: Death, Fatigue, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Crohn's Disease
Sandostatin
Dosage: 500 ug, bid
Indication: Neoplasm Malignant
Start date: 2012-06-28
Sandostatin LAR
Dosage: 20 mg once a month
Indication: Neoplasm Malignant
Start date: 2012-06-28
End date: 2012-06-28
Sandostatin LAR
Indication: Crohn's Disease
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-07
Patient: female
Reactions: Fatigue, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 500 ug, bid
Indication: Neoplasm Malignant
Start date: 2012-06-28
Sandostatin
Indication: Crohn's Disease
Sandostatin LAR
Indication: Crohn's Disease
Sandostatin LAR
Dosage: 20 mg once a month
Indication: Neoplasm Malignant
Start date: 2012-06-28
End date: 2012-06-28
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-06
Patient: male
Reactions: Blood Bilirubin Increased, Confusional State, Weight Decreased, Abdominal Pain, Agitation, Jaundice, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Fatigue, Malaise, Pleural Effusion, Cough, Decreased Appetite, Lethargy, Cardiac Failure Congestive, Blood Pressure Increased, Dyspnoea, Pain in Extremity, Restlessness, Discomfort, Ascites, Syncope, Abdominal Mass, Heart Rate Decreased, Joint Swelling, Micturition Disorder, Urine Colour Abnormal, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Sandostatin LAR
Dosage: 20 mg, once in a month
Indication: Neuroendocrine Tumour
Start date: 2011-02-28
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Other drugs received by patient: Sutent
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-03
Patient: male
Reactions: Abdominal Pain, Nasopharyngitis, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Diarrhoea, Gastrointestinal Neoplasm, Neoplasm Malignant, Dysphonia, Arthralgia, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Morphine Sulfate
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-08-01
Patient: female
Reactions: Haemorrhage, Rectal Haemorrhage, Malaise, Fatigue, White Blood Cell Count Increased, Lethargy, Vomiting, Loss of Control of Legs, Nausea, Urinary Tract Infection, Injection Site Pain, Facial Pain, Blood Creatine Increased, Tremor, Discomfort, Haemoglobin Decreased, Diarrhoea, Liver Abscess, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Carcinoid Tumour
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Start date: 2011-07-05
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Carcinoid Tumour
Start date: 2011-07-05
Other drugs received by patient: Norfloxacin
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-07-25
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Confusional State, Weight Decreased, Incorrect Route of Drug Administration, Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Discomfort, Injection Site Erythema, Malaise, Fatigue, Hot Flush, Oedema Peripheral, Dizziness, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2012-05-04
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-24
Patient: female
Reactions: Abdominal Pain, Blood Growth Hormone Increased, Blood Pressure Systolic Increased, Mass, Necrosis, Acne, Loss of Consciousness, Abdominal Pain Upper, Fatigue, Arthralgia, Injection Site Calcification, Dizziness, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: 3 df, (3 times per night)
Indication: Headache
Sandostatin LAR
Dosage: 40 mg every 3 weeks
Indication: Acromegaly
Start date: 2004-07-15
Other drugs received by patient: Avalide; Avapro
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-19
Patient: female
Reactions: Fatigue, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Crohn's Disease
Sandostatin
Dosage: 500 ug, bid
Indication: Neoplasm Malignant
Start date: 2012-06-28
Sandostatin LAR
Indication: Crohn's Disease
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neoplasm Malignant
Start date: 2012-06-28
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-17
Patient: female
Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Dizziness, Abdominal Distension, Anuria, Blood Pressure Increased, Back Pain, Humerus Fracture, Gastrointestinal Motility Disorder, Vomiting, Pain in Extremity, Nausea, Flushing, Arthralgia, Diarrhoea, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Indication: Small Intestine Carcinoma
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, tiw
Indication: Small Intestine Carcinoma
Start date: 2009-05-26
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 30 mg, tiw
Other drugs received by patient: Xeloda; Capecitabine
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-04
Patient: female
Reactions: Pneumonia, Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-06-28
Patient: female
Reactions: Abdominal Pain, Blood Pressure Increased, Blood Growth Hormone Increased, Mass, Blood Pressure Systolic Increased, Necrosis, Acne, Loss of Consciousness, Abdominal Pain Upper, Fatigue, Injection Site Calcification, Arthralgia, Dizziness, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: 3 df, (3 times per night)
Indication: Headache
Sandostatin LAR
Dosage: 40 mg every 3 weeks
Indication: Acromegaly
Start date: 2004-07-15
Other drugs received by patient: Avalide
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-26
Patient: female
Reactions: Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-06-06
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Confusional State, Weight Decreased, Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Erythema, Fatigue, Injection Site Discomfort, Malaise, Hot Flush, Oedema Peripheral, Dizziness, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Blood Pressure Systolic Increased, Pain in Extremity, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2012-05-04
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, qmo
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-06-01
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Neoplasm Malignant, Dysphonia, Gastrointestinal Neoplasm, Diarrhoea, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Other drugs received by patient: Morphine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-30
Patient: female
Reactions: Nasopharyngitis, Flatulence, Neoplasm Progression, Synovial Cyst, Fatigue, Malaise, Oedema Peripheral, Proctalgia, Cough, Viral Infection, Nausea, Abnormal Faeces, Faecal Incontinence, Diarrhoea, Joint Swelling, Influenza Like Illness
Drug(s) suspected as cause:
Sandostatin
Indication: Neuroendocrine Carcinoma
Start date: 2011-11-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Carcinoma
Start date: 2011-11-25
Other drugs received by patient: Other Anti-Asthmatics, Inhalants
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-28
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Confusional State, Weight Decreased, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Fatigue, Injection Site Discomfort, Injection Site Erythema, Malaise, Hot Flush, Oedema Peripheral, Abdominal Distension, Dizziness, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, qmo
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-28
Patient: female
Reactions: Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Abdominal Discomfort, Malaise, Fatigue, Diarrhoea, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-25
Patient: female
Reactions: Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-22
Patient: female
Reactions: Nasopharyngitis, Flatulence, Neoplasm Progression, Synovial Cyst, Malaise, Fatigue, Oedema Peripheral, Cough, Proctalgia, Viral Infection, Nausea, Abnormal Faeces, Faecal Incontinence, Diarrhoea, Joint Swelling, Influenza Like Illness
Drug(s) suspected as cause:
Sandostatin
Indication: Neuroendocrine Carcinoma
Start date: 2011-11-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Carcinoma
Start date: 2011-11-25
Other drugs received by patient: Other Anti-Asthmatics, Inhalants
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-18
Patient: female
Reactions: Abdominal Pain, Blood Growth Hormone Increased, Blood Pressure Systolic Increased, Mass, Necrosis, Acne, Abdominal Pain Upper, Fatigue, Injection Site Calcification, Arthralgia, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: 3 df, (3 times per night)
Indication: Headache
Sandostatin LAR
Dosage: 40 mg every 3 weeks
Indication: Acromegaly
Start date: 2004-07-15
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-14
Patient: female
Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Abdominal Distension, Dizziness, Back Pain, Blood Pressure Increased, Humerus Fracture, Vomiting, Nausea, Pain in Extremity, Flushing, Diarrhoea, Arthralgia, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Indication: Small Intestine Carcinoma
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, tiw
Indication: Small Intestine Carcinoma
Start date: 2009-05-26
Sandostatin LAR
Dosage: 30 mg, every three weeks
Other drugs received by patient: Xeloda; Capecitabine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-09
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Weight Decreased, Confusional State, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Hot Flush, Malaise, Injection Site Erythema, Fatigue, Oedema Peripheral, Abdominal Distension, Dizziness, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-05-09
Patient: male
Reactions: Weight Decreased, Abdominal Pain, Nasopharyngitis, Mouth Ulceration, Skin Burning Sensation, Oropharyngeal Pain, Erythema, Gastritis, Haematemesis, Abdominal Discomfort, Hot Flush, Fatigue, Injection Site Induration, Decreased Appetite, Cough, Injection Site Mass, Vomiting, Stomatitis, Nausea, Injection Site Pain, Diarrhoea, Hypophagia, Rash Maculo-Papular, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 500 ug, bid
Start date: 2011-08-25
Sandostatin
Dosage: 150 ug, bid
Start date: 2011-02-14
End date: 2011-02-17
Sandostatin
Dosage: 250 ug, bid
Start date: 2011-06-08
Sandostatin
Dosage: 500 ug, bid
Start date: 2011-08-25
Sandostatin
Dosage: 100 ug, tid
Indication: Neuroendocrine Tumour
Start date: 2011-02-01
End date: 2011-02-14
Sandostatin
Dosage: 500 ug, tid
Sandostatin LAR
Dosage: 40 mg, every three weeks
End date: 2011-06-08
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 40 mg every three weeks
End date: 2011-05-21
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2009-09-10
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 40 mg, qmo
Other drugs received by patient: Mesalamine; Insulin; Aspirin; Gravol TAB; Fragmin; Pantoprazole Sodium
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-09
Patient: female
Reactions: Viral Infection, Nasopharyngitis, Nausea, Abnormal Faeces, Flatulence, Faecal Incontinence, Synovial Cyst, Fatigue, Malaise, Diarrhoea, Joint Swelling, Oedema Peripheral, Proctalgia, Cough, Influenza Like Illness
Drug(s) suspected as cause:
Sandostatin
Indication: Neuroendocrine Carcinoma
Start date: 2011-11-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Carcinoma
Start date: 2011-11-25
Other drugs received by patient: Other Anti-Asthmatics, Inhalants
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-04-30
Patient: female
Reactions: Abdominal Discomfort, Malaise, Fatigue, Blood Pressure Systolic Increased, Diarrhoea, Mental Disorder, Vasculitis, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Page 1 Next >>
|
